@drtimos.bsky.socialWhat if strategy felt like live chess?
#LucidWargames runs dynamic sims, pits you vs adaptive AI rivals, adjudicates by KPIs, and maps odds with 100+ Monte Carlo runs.
Prep or power your next session with rigor: http://dlvr.it/TVc4PY
Demo: http://dlvr.it/TVc4Pp
#LucidQuest
@drtimos.bsky.socialFrom slides to simulations. #LucidWargames, a multi-agent engine, pressure tests strategy with evolving scenarios, objective scoring, and probability maps from 100+ Monte Carlo runs. Optimize your next workshop: http://dlvr.it/TVbhy2 Demo: http://dlvr.it/TVbhyB #LucidQuest
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVbXz1 !
@drtimos.bsky.socialStay ahead in healthcare innovation.
Subscribe to #LucidQuest's Weekly LQ AI Report for #AI breakthroughs, #PrecisionMedicine insights & #DigitalHealth trends.
Get tips & success stories delivered to your inbox. http://dlvr.it/TVbGf5
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVZrrx
@ASCO
#SocialListening #LucidQuest
@drtimos.bsky.socialLucidQuest YouTube > Hematology Strategic Roundup | Aug 14, 2026- Sep 17 2026: From 14 August to 17 September 2026, hematology competition increasingly shifted beyond efficacy toward how high-efficacy therapies can fit more effectively into real-world… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social#LucidQuest helps Pharma/Biotech/HealthTech teams turn market signals into decisions, fast.
Start with #QuickAnswers (rapid primary + secondary CI), scale to deeper projects, conference coverage, #LucidWargames simulations, #LucidScope AI narrative audits, and #NexusBrain insight capture.
@drtimos.bsky.social🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TVZNZS | 📧 Talk to experts: [email protected]
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVYrKq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
@drtimos.bsky.social💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 [email protected] or http://dlvr.it/TVYpNH
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
@drtimos.bsky.social🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVYYdX
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights
@drtimos.bsky.socialMost biopharma launch plans fail not on intent, but on untested response. Competitors counter. Payers retaliate. Regulators reshape rules.
#LucidWargames stress-tests commercial decisions against adversarial behavior, before they’re irreversible.
@drtimos.bsky.socialWin AI search for your brand: structure trials (PMC), align patient portals, publish side-by-sides, frame safety, and own your canonicals.
More: http://dlvr.it/TVYHlP #AIsearch #HealthcareAI #LucidQuest
@drtimos.bsky.socialAI shapes how patients & clinicians find you. Be consistent across sources, make trials citable, answer comparative queries, and audit AI outputs.
Learn how: http://dlvr.it/TVYFlK #AIsearch #HealthTech #LucidQuest
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVXxWK
#CompetitiveIntelligence #Strategy #MarketAccess
@drtimos.bsky.social📊 Investment Insights | Advisory | #Fundraising 🚀
At #LucidQuest we help funds & founders turn intelligence into alpha—fast, evidence-based answers before capital moves.
📩 [email protected] or http://dlvr.it/TVXnw9
#VentureCapital #PrivateEquity #HedgeFunds #DealFlow
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVXSrc
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVXSrj
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVX4bL
